Showing results (2101-2110 of 2,620) with videos related to
Sort By:
Pageof 262
The Journal of Infectious Diseases|July 27, 2016
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge ModelsReed F Johnson, Drishya Kurup, Katie R Hagen, et al.Journal of Virology|January 5, 2023
Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret ModelHannah M Creager, Troy J Kieran, Hui Zeng, et al.Plos Medicine|April 16, 2013
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studiesLeigh F Johnson, Joel Mossong, Rob E Dorrington, et al.Cell Metabolism|June 9, 2015
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseEmma Börgeson, Andrew M F Johnson, Yun Sok Lee, et al.Nature Communications|May 5, 2018
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's diseaseZhi-Hao Wang, Ke Gong, Xia Liu, et al.Molecular Endocrinology (Baltimore, Md.)|August 2, 2016
Minireview: Endocrine Disruptors: Past Lessons and Future DirectionsThaddeus T Schug, Anne F Johnson, Linda S Birnbaum, et al.Plos Pathogens|April 21, 2025
Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challengeHong-Su Park, Yumiko Matsuoka, Celia Santos, et al.Pharmaceutical Biology|April 12, 2017
Isolation and identification of compounds from Kalanchoe pinnata having human alphaherpesvirus and vaccinia virus antiviral activityMatthew Cryer, Kyle Lane, Mary Greer, et al.Biorxiv : the Preprint Server for Biology|October 7, 2024
Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challengeHong-Su Park, Yumiko Matsuoka, Celia Santos, et al.Journal of Virology|August 19, 2011
Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola virusesJoseph E Blaney, Christoph Wirblich, Amy B Papaneri, et al.Pageof 262